Hightower can contribute to technical due diligence associated with mergers, acquisitions, and product licensing.
Hightower can help you select drug delivery technology for your new chemical entity.
Hightower can lead the selection and management of contract research organizations.
Hightower can direct the development and validation of analytical methods applied to drug substances, drug products, and biological samples.
Hightower can direct and interpret the pre-formulation characterization of your new chemical entity.
Hightower can direct the work necessary to remediate CMC deficiencies and can craft descriptive FDA responses.
Dr. Bannister can serve as a consulting or testifying expert on drug-analysis, drug-development, and drug-manufacturing issues for counsel in civil and criminal cases.